Scotia Capital Inc. Arrowhead Pharmaceuticals, Inc. Transaction History

Scotia Capital Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$27.79 - $50.61 $190,333 - $346,627	-6,849 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$39.62 - $69.97 $55,428 - $97,888	1,399 Added 25.67%	6,849 $315,000
Q4 2021 Feb 11, 2022	SELL	$58.09 - $82.51 $11,211 - $15,924	-193 Reduced 3.42%	5,450 $361,000
Q3 2021 Nov 12, 2021	BUY	$58.38 - $84.96 $74,901 - $109,003	1,283 Added 29.43%	5,643 $352,000
Q2 2021 Aug 12, 2021	BUY	$62.15 - $90.32 $270,974 - $393,795	4,360 New	4,360 $361,000

295

92.3M

1.33M

549K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Scotia Capital Inc., based on Form 13F filings with the SEC.

Stay updated on Scotia Capital Inc. with notifications on news.